📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age. (2015)

First Author: Tapia MD

Attributed to: Childhood tuberculosis: Integrating tools for improved diagnosis and vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/civ672

PubMed Identifier: 26553683

Publication URI: http://europepmc.org/abstract/MED/26553683

Type: Journal Article/Review

Volume: 61 Suppl 5

Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Issue: Suppl 5

ISSN: 1058-4838